Bicyclo[2.2.1]heptan-2-amine,N,2,3,3-tetramethyl-, hydrochloride (1:1) cas no:826-39-1
Synonyms: 2-Norbornanamine,N,2,3,3-tetramethyl-, hydrochloride (8CI);Bicyclo[2.2.1]heptan-2-amine,N,2,3,3-tetramethyl-, hydrochloride (9CI);CPDD 0059;Inversine;Mecamylaminechloride;Mevasin;Mevasine;N,2,3,3-Tetramethyl-2-norbornanamine hydrochloride;
NameBicyclo[2.2.1]heptan-2-amine,N,2,3,3-tetramethyl-, hydrochloride (1:1)
CAS826-39-1
Synonyms2-Norbornanamine,N,2,3,3-tetramethyl-, hydrochloride (8CI);Bicyclo[2.2.1]heptan-2-amine,N,2,3,3-tetramethyl-, hydrochloride (9CI);CPDD 0059;Inversine;Mecamylaminechloride;Mevasin;Mevasine;N,2,3,3-Tetramethyl-2-norbornanamine hydrochloride;
EINECS(EC#)212-555-8
Molecular FormulaC11H21N.HCl
Molecular Weight203.79
Appearancewhite solid
storage tempDesiccate at RT
Hazard Xn: Harmful;
Risk R22;R36/37/38
Safety
Poison by ingestion, intraperitoneal, intravenous, and subcutaneous routes. When heated to decomposition it emits very toxic fumes of HCl and NOx.
Hazard Codes:
Xn
Risk Statements:
R22:Harmful if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements:
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
RIDADR: UN 2811 6.1/PG 3
WGK Germany: 3
RTECS: RB6900000
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| guinea pig |
LD50 |
intraperitoneal |
63mg/kg (63mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 169, 1956. |
| guinea pig |
LD50 |
oral |
175mg/kg (175mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 169, 1956. |
| guinea pig |
LD50 |
subcutaneous |
155mg/kg (155mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 169, 1956. |
| mouse |
LD50 |
intraperitoneal |
17mg/kg (17mg/kg) |
|
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 300, 1970. |
| mouse |
LD50 |
intravenous |
14mg/kg (14mg/kg) |
|
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 300, 1970. |
| mouse |
LD50 |
oral |
92mg/kg (92mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 814, 1982. |
| mouse |
LD50 |
subcutaneous |
81mg/kg (81mg/kg) |
|
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 300, 1970. |
| rat |
LD50 |
intraperitoneal |
53mg/kg (53mg/kg) |
|
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 301, 1970. |
| rat |
LD50 |
intravenous |
21mg/kg (21mg/kg) |
|
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 300, 1970. |
| rat |
LD50 |
oral |
208mg/kg (208mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 169, 1956. |
| rat |
LD50 |
subcutaneous |
177mg/kg (177mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 117, Pg. 169, 1956. |
